Molecular Mechanism and Potential Clinical Value of CMTMFamily Members in Tumor Cells
10.13865/j.cnki.cjbmb.2021.04.1700
- Author:
Hui JIANG
1
;
Xiao-Xiao MOU
2
;
Xiao-Yun YANG
2
Author Information
1. Department of Clinical Medicine, Weifang Medical University
2. Department of Biochemistry and MolecularBiology, Weifang Medical University
- Publication Type:Journal Article
- Keywords:
cellular signalingpathways;
chemokine-like factor super family (CKLFSF / CMTM);
clinical value;
tumor
- From:
Chinese Journal of Biochemistry and Molecular Biology
2022;38(1):28-34
- CountryChina
- Language:Chinese
-
Abstract:
Nowadays, malignant tumor has become an important killer endangering human health, and the research on tumor has become a hot spot in the medical field. The CKLF-like MARVEL transmembrane domain containing family of genes (CMTM family), previously called chemokine-like factor super family (CKLFSF). CMTM family is a novel gene family firstly discovered by Chinese scholars and has a wide range of biological functions, which is closely related to human immune, hematopoietic and reproductive systems as well as tumors. CMTM family is dysregulated in many common tumors, can participate in a variety of signaling pathways closely related to the occurrence and development of cancer, which is closely related to the biological behavior changes of tumor cells. CMTM family members play an important role in the signaling molecular mechanisms that regulate the biological function of tumor cells and are able to regulate the signaling pathways of the tumor cell cycle and apoptosis. Including epithelial-mesenchymal transition process, epidermal growth factor receptor related signaling pathways, and closely related to the tumor immune microenvironment by regulating programmed death receptor-ligand 1. In this paper, we review the signaling molecular mechanisms of CMTM family in the biological processes of tumor cell proliferation, migration, invasion and apoptosis, as well as the potential clinical applications of CMTM family in ovarian cancer, breast cancer, liver cancer, gastric cancer, colorectal cancer, pancreatic cancer and other common malignant tumors. At present, the detailed molecular mechanism ofCMTM family related to tumor has not been fully clarified. Further study of the expression, biological role and regulatory mechanism of CMTM family in tumor will provide new ideas and targets for tumordiagnosis, treatment and prognosis prediction.
